Variant Summary
- HGVS
- —
- Variant Type(s)
- transcript_amplification
- Evidence Items
- 3
Evidence Level Distribution
Level B: 2Level D: 1
Evidence Items
Showing CIViC evidence rows where gene = KRAS and variant = Amplification.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| B | Prognostic | Supports | Poor Outcome | Endometrial Cancer | 3 | |
| B | Predictive | Supports | Sensitivity/Response | Skin Melanoma | Sorafenib,Carboplatin,Docetaxel | 2 |
| D | Predictive | Supports | Resistance | Melanoma | Vemurafenib | 2 |